Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,009,867
+$546,913 QoQ
Shares Held
41,938
+154.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
#1,321
of 2,821 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,883,056
PutShares
78,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Volterra Technologies LP holds $2,250,077 across 2 Drug Manufacturers - General names. PFE ranks #2 (44.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,034 | $1,240,210 | |
| 2 | PFE |
Pfizer Inc
This page
|
41,938 | $1,009,867 |
All Filings in PFE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,009,867 | 41,938 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $1,883,056 | 78,200 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $462,954 | 16,487 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $7,478,040 | 308,500 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $5,996,976 | 247,400 | Put | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||